{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:17:37Z","timestamp":1790007457603,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019266","name":"Korea Medical Device Development Fund","doi-asserted-by":"publisher","award":["RS-2022-00140710"],"award-info":[{"award-number":["RS-2022-00140710"]}],"id":[{"id":"10.13039\/100019266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Radiofrequency ablation (RFA) is increasingly being investigated as a treatment for parathyroid lesions, with favorable outcomes, especially in patients who are ineligible for surgery or decline surgery. We aimed to assess the efficacy and safety of RFA in treating hyperparathyroidism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>PubMed and Embase were searched for original literature published on or before July 18, 2024. We included 14 eligible studies with 593 patients (241 with primary hyperparathyroidism [PHPT], 310 with secondary hyperparathyroidism [SHPT], and 42 with tertiary hyperparathyroidism [THPT]). Serial pooled means of biochemical indexes (parathyroid hormone [PTH], calcium, phosphorus), volume reduction ratio (VRR) after RFA, and complication rate were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In PHPT, the pooled mean baseline PTH value of 158.7\u2009pg\/mL and serum calcium value of 10.96\u2009mg\/dL significantly decreased to 57.3\u2009pg\/mL and 9.55\u2009mg\/dL, respectively, at 12 months (both <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), with both being within normal ranges. The pooled mean VRR gradually increased, reaching 95.6% at 12 months. In SHPT, the pooled mean baseline PTH value of 1683.7\u2009pg\/mL significantly decreased to 267.2\u2009pg\/mL at 12 months (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), which was within the target reference level (PTH\u2009\u2264\u2009585\u2009pg\/mL). In THPT, the mean baseline PTH value of 1284.9\u2009pg\/mL decreased to 161.6\u2009pg\/mL at 1 year (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The pooled incidence rates of total, major, and minor complications were 27.9%, 7.5%, and 20.0%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>RFA showed promising effectiveness and safety profiles, particularly for patients who are ineligible for surgery or decline surgical intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>What is the efficacy and safety of RFA in treating hyperparathyroidism?<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>In PHPT, pooled mean values of biochemical indexes (serum PTH, calcium) were normal throughout 12-month follow-up. In SHPT and THPT, pooled mean PTH stayed within target ranges throughout 12-month follow-up.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>RFA showed efficacy and safety in treating hyperparathyroidism, maintaining biochemical indexes within normal or target ranges throughout 12-month follow-ups. RFA would be a valuable treatment option for patients who are ineligible for surgery or who decline surgical intervention<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00330-025-11581-6","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:21:30Z","timestamp":1744885290000},"page":"6583-6597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of radiofrequency ablation for hyperparathyroidism: a meta-analysis and systematic review"],"prefix":"10.1007","volume":"35","author":[{"given":"So Yeong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehyuk","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunjong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inpyeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6349-6950","authenticated-orcid":false,"given":"Ji-hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"11581_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"11581_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959\u2013968","journal-title":"JAMA Surg"},{"key":"11581_CR3","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/SLA.0000000000005522","volume":"276","author":"S Dream","year":"2022","unstructured":"Dream S, Kuo LE, Kuo JH et al (2022) The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg 276:e141\u2013e176","journal-title":"Ann Surg"},{"key":"11581_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-016-5694-1","volume":"24","author":"M Jinih","year":"2017","unstructured":"Jinih M, O\u2019Connell E, O\u2019Leary DP, Liew A, Redmond HP (2017) Focused versus bilateral parathyroid exploration for primary hyperparathyroidism: a systematic review and meta-analysis. Ann Surg Oncol 24:1924\u20131934. https:\/\/doi.org\/10.1245\/s10434-016-5694-1","journal-title":"Ann Surg Oncol"},{"key":"11581_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrendo.2009.142","volume":"5","author":"NA Hamdy","year":"2009","unstructured":"Hamdy NA (2009) Parathyroid gland: Is parathyroidectomy safe and beneficial in the elderly?. Nat Rev Endocrinol 5:422\u2013423. https:\/\/doi.org\/10.1038\/nrendo.2009.142","journal-title":"Nat Rev Endocrinol"},{"key":"11581_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1148\/radiol.11091126","volume":"260","author":"DE Dupuy","year":"2011","unstructured":"Dupuy DE (2011) Image-guided thermal ablation of lung malignancies. Radiology 260:633\u2013655. https:\/\/doi.org\/10.1148\/radiol.11091126","journal-title":"Radiology"},{"key":"11581_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1148\/radiol.2481071448","volume":"248","author":"PV Pandharipande","year":"2008","unstructured":"Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS (2008) Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 248:169\u2013178. https:\/\/doi.org\/10.1148\/radiol.2481071448","journal-title":"Radiology"},{"key":"11581_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1148\/radiol.11110637","volume":"262","author":"ZW Peng","year":"2012","unstructured":"Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS (2012) Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 262:689\u2013700. https:\/\/doi.org\/10.1148\/radiol.11110637","journal-title":"Radiology"},{"key":"11581_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3348\/kjr.2020.0037","volume":"21","author":"EJ Ha","year":"2020","unstructured":"Ha EJ, Baek JH, Baek SM (2020) Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol 21:1383\u20131392. https:\/\/doi.org\/10.3348\/kjr.2020.0037","journal-title":"Korean J Radiol"},{"key":"11581_CR10","doi-asserted-by":"publisher","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W-65\u2013W-94","journal-title":"Ann Intern Med"},{"key":"11581_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"11581_CR12","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D (2003) Society of interventional radiology clinical practice guidelines. J Vasc Inter Radio 14:S199\u2013S202","journal-title":"J Vasc Inter Radio"},{"key":"11581_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1148\/radiol.2282021787","volume":"228","author":"SN Goldberg","year":"2003","unstructured":"Goldberg SN, Charboneau JW, Dodd IIIGD et al (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228:335\u2013345","journal-title":"Radiology"},{"key":"11581_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ et al (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408\u2013414","journal-title":"J Clin Epidemiol"},{"key":"11581_CR15","unstructured":"Kim S, Seo H, Lee Y, Park J (2013) Study design algorithm for medical literature of intervention (DAMI) and risk of bias for nonrandomized studies (robans) ver 2.0 by HIRA. Health Insurance Review & Assessment Service, Seoul, pp 65\u201366"},{"key":"11581_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/096228029300200202","volume":"2","author":"JL Fleiss","year":"1993","unstructured":"Fleiss JL (1993) The statistical basis of meta-analysis. Stat Methods Med Res 2:121\u2013145. https:\/\/doi.org\/10.1177\/096228029300200202","journal-title":"Stat Methods Med Res"},{"key":"11581_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"11581_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"11581_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ekir.2021.11.038","volume":"7","author":"DL Zhang","year":"2022","unstructured":"Zhang DL, Chen S, Gao MZ et al (2022) Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep 7:282\u2013288. https:\/\/doi.org\/10.1016\/j.ekir.2021.11.038","journal-title":"Kidney Int Rep"},{"key":"11581_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44204-5","volume":"13","author":"X Qiu","year":"2023","unstructured":"Qiu X, Gao M, Zhang D, Ji F (2023) Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study. Sci Rep 13: 16949. https:\/\/doi.org\/10.1038\/s41598-023-44204-5","journal-title":"Sci Rep"},{"key":"11581_CR21","doi-asserted-by":"crossref","unstructured":"Khandelwal AH, Batra S, Jajodia S et al (2020) Radiofrequency ablation of parathyroid adenomas: safety and efficacy in a study of 10 patients. Indian J Endocrinol Metab. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7906106\/pdf\/IJEM-24-543.pdf","DOI":"10.4103\/ijem.IJEM_671_20"},{"key":"11581_CR22","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s40618-023-02078-4","volume":"46","author":"S Le\u00f3n Utrero","year":"2023","unstructured":"Le\u00f3n Utrero S, Garrido-Pareja F, L\u00f3pez-Ibarra P et al (2023) Effectiveness and safety of the radiofrequency ablation of single hyperfunctioning parathyroid lesions suggestive of adenomas in primary hyperparathyroidism. J Endocrinol Invest 46:2269\u20132273. https:\/\/doi.org\/10.1007\/s40618-023-02078-4","journal-title":"J Endocrinol Invest"},{"key":"11581_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.eprac.2021.07.012","volume":"27","author":"X Li","year":"2021","unstructured":"Li X, Tufano RP, Russell JO et al (2021) Ultrasound-guided radiofrequency ablation for the treatment of primary hyperparathyroidism: an efficacy and safety study. Endocr Pract 27:1205\u20131211. https:\/\/doi.org\/10.1016\/j.eprac.2021.07.012","journal-title":"Endocr Pract"},{"key":"11581_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/02656736.2022.2047231","volume":"39","author":"C-Z Peng","year":"2022","unstructured":"Peng C-Z, Chai H-H, Zhang Z-X et al (2022) Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int J Hyperth 39:490\u2013496","journal-title":"Int J Hyperth"},{"key":"11581_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12020-023-03513-5","volume":"83","author":"T Jiang","year":"2024","unstructured":"Jiang T, Deng E, Chai H et al (2024) Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience. Endocrine 83:681\u2013690. https:\/\/doi.org\/10.1007\/s12020-023-03513-5","journal-title":"Endocrine"},{"key":"11581_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/0886022x.2021.1889601","volume":"43","author":"X Qin","year":"2021","unstructured":"Qin X, Wang B, Li B, Lin C, Liu X, Xie X (2021) Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism. Ren Fail 43:445\u2013451. https:\/\/doi.org\/10.1080\/0886022x.2021.1889601","journal-title":"Ren Fail"},{"key":"11581_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14623-x","volume":"12","author":"M Ren","year":"2022","unstructured":"Ren M, Zheng D, Wu J et al (2022) Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep 12: 10289. https:\/\/doi.org\/10.1038\/s41598-022-14623-x","journal-title":"Sci Rep"},{"key":"11581_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00270-024-03725-w","volume":"47","author":"H Chehrehgosha","year":"2024","unstructured":"Chehrehgosha H, Chegini H, Heydari I, Ebrahiminik H, Salouti R, Golzarian J (2024) Radiofrequency ablation of parathyroid adenoma: results of a retrospective analysis of 60 patients. Cardiovasc Interv Radio 47:762\u2013770. https:\/\/doi.org\/10.1007\/s00270-024-03725-w","journal-title":"Cardiovasc Interv Radio"},{"key":"11581_CR29","doi-asserted-by":"publisher","first-page":"e231852","DOI":"10.1148\/radiol.231852","volume":"311","author":"W Yue","year":"2024","unstructured":"Yue W, Jiang T, Ai Z et al (2024) US-guided percutaneous radiofrequency ablation for secondary hyperparathyroidism: long-term outcomes and prognostic factors. Radiology 311:e231852. https:\/\/doi.org\/10.1148\/radiol.231852","journal-title":"Radiology"},{"key":"11581_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3348\/kjr.2023.0176","volume":"25","author":"E Deng","year":"2024","unstructured":"Deng E, Jiang T, Chai H et al (2024) Ultrasound-guided radiofrequency ablation in tertiary hyperparathyroidism: a prospective study. Korean J Radio 25:289\u2013300. https:\/\/doi.org\/10.3348\/kjr.2023.0176","journal-title":"Korean J Radio"},{"key":"11581_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/02656736.2022.2097324","volume":"39","author":"CC Chen","year":"2022","unstructured":"Chen CC, Chen HL, Chiang PL et al (2022) Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. Int J Hyperth 39:907\u2013917. https:\/\/doi.org\/10.1080\/02656736.2022.2097324","journal-title":"Int J Hyperth"},{"key":"11581_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.7326\/m17-2640","volume":"168","author":"M Ketteler","year":"2018","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2018) Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med 168:422\u2013430. https:\/\/doi.org\/10.7326\/m17-2640","journal-title":"Ann Intern Med"},{"key":"11581_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/02656736.2021.1885754","volume":"38","author":"Z Diao","year":"2021","unstructured":"Diao Z, Qian L, Teng C et al (2021) Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. Int J Hyperth 38:213\u2013219. https:\/\/doi.org\/10.1080\/02656736.2021.1885754","journal-title":"Int J Hyperth"},{"key":"11581_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/hdi.12740","volume":"23","author":"B Jiang","year":"2019","unstructured":"Jiang B, Wang X, Yao Z et al (2019) Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial Int 23:247\u2013253. https:\/\/doi.org\/10.1111\/hdi.12740","journal-title":"Hemodial Int"},{"key":"11581_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/02656736.2019.1645365","volume":"36","author":"F Liu","year":"2019","unstructured":"Liu F, Yu X, Liu Z et al (2019) Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperth 36:835\u2013840. https:\/\/doi.org\/10.1080\/02656736.2019.1645365","journal-title":"Int J Hyperth"},{"key":"11581_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/02656736.2021.1904153","volume":"38","author":"J Zhao","year":"2021","unstructured":"Zhao J, Qian L, Teng C et al (2021) A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism. Int J Hyperth 38:1558\u20131565. https:\/\/doi.org\/10.1080\/02656736.2021.1904153","journal-title":"Int J Hyperth"},{"key":"11581_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/02656736.2020.1785557","volume":"37","author":"Y Wei","year":"2020","unstructured":"Wei Y, Yu MA, Qian LX et al (2020) Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: a retrospective study. Int J Hyperth 37:819\u2013825. https:\/\/doi.org\/10.1080\/02656736.2020.1785557","journal-title":"Int J Hyperth"},{"key":"11581_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijsu.2019.08.004","volume":"70","author":"L Gong","year":"2019","unstructured":"Gong L, Tang W, Lu J, Xu W (2019) Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg 70:13\u201318. https:\/\/doi.org\/10.1016\/j.ijsu.2019.08.004","journal-title":"Int J Surg"},{"key":"11581_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.asjsur.2019.12.003","volume":"43","author":"N Lin","year":"2020","unstructured":"Lin N, Fang Y, Yu C, Wang Y (2020) A useful treatment for recurrent secondary hyperparathyroidism after Parathyroidectomy: A case report. Asian J Surg 43:573\u2013574","journal-title":"Asian J Surg"},{"key":"11581_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/02656736.2019.1684576","volume":"36","author":"Z Hu","year":"2019","unstructured":"Hu Z, Han E, Chen W, Chen J, Chen W, Guo R (2019) Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism. Int J Hyperth 36:1128\u20131135","journal-title":"Int J Hyperth"},{"key":"11581_CR41","doi-asserted-by":"publisher","first-page":"2256497","DOI":"10.1080\/02656736.2023.2256497","volume":"40","author":"B Yu","year":"2023","unstructured":"Yu B, Li J, Lu C, Lu Q, Zhou Y, Luo Y (2023) Ultrasound-guided microwave ablation for tertiary hyperparathyroidism in patients with renal transplantation. Int J Hyperth 40:2256497. https:\/\/doi.org\/10.1080\/02656736.2023.2256497","journal-title":"Int J Hyperth"},{"key":"11581_CR42","doi-asserted-by":"publisher","first-page":"2308063","DOI":"10.1080\/02656736.2024.2308063","volume":"41","author":"Y Wei","year":"2024","unstructured":"Wei Y, Zhao Z-l, Wu J et al (2024) Complications of microwave ablation in patients with persistent\/recurrent hyperparathyroidism after surgical or ablative treatment. Int J Hyperth 41:2308063","journal-title":"Int J Hyperth"},{"key":"11581_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/02656736.2020.1744741","volume":"37","author":"XJ Cao","year":"2020","unstructured":"Cao XJ, Zhao ZL, Wei Y, Peng LL, Li Y, Yu MA (2020) Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis. Int J Hyperth 37:316\u2013323","journal-title":"Int J Hyperth"},{"key":"11581_CR44","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","volume":"106","author":"Y Wei","year":"2021","unstructured":"Wei Y, Peng CZ, Wang SR et al (2021) Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab 106:2707\u20132717. https:\/\/doi.org\/10.1210\/clinem\/dgab240","journal-title":"J Clin Endocrinol Metab"},{"key":"11581_CR45","doi-asserted-by":"crossref","unstructured":"Liu F, Liu Y, Peng C et al (2022) Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study. Eur Radiol 32:7743\u20137754","DOI":"10.1007\/s00330-022-08851-y"},{"key":"11581_CR46","doi-asserted-by":"crossref","unstructured":"Xu W, Li S, Cheng F et al (2023) Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis. Int Urol Nephrol 55:2237\u20132247","DOI":"10.1007\/s11255-023-03543-y"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11581-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:09:21Z","timestamp":1757498961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11581-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["11581"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11581-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Ji-hoon Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"JYL is a member of the Scientific Editorial Board of European Radiology (section: Head and Neck). As such, they did not participate in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because it is a meta-analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because this study is a meta-analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}